Immune-mediated neutropenia in the neonate.
Alloimmune neonatal neutropenia, neonatal autoimmune neutropenia and autoimmune neutropenia of infancy have remained nebulous entities with difficulties in both clinical and laboratory identification. These disorders are reviewed in this article.
Maheshwari
A
A
Christensen
R D
RD
Calhoun
D A
DA
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001324:Autoantigens / Q000032:analysis; D001327:Autoimmune Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology*; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D015994:Incidence; D007231:Infant, Newborn; D007363:Intensive Care Units, Neonatal; D008297:Male; D009503:Neutropenia / Q000188:drug therapy / Q000453:epidemiology* / Q000276:immunology*; D011379:Prognosis; D011994:Recombinant Proteins; D018570:Risk Assessment; D012307:Risk Factors; D015996:Survival Rate
D000305:Adrenal Cortex Hormones; D001324:Autoantigens; D016756:Immunoglobulins, Intravenous; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor